Χαμπαίος Ιωάννης, Καθηγητής

Ιατρική σχολή Πανεπιστημίου Πατρών κτήριο προκλινικών 3ος όροφος δυτική πτέρυγα

2610969130 ihabeos@med.upatras.gr

Ανάκτηση Βιογραφικού Σημειώματος

Περίληψη Βιογραφικού Σημειώματος

Name: IOANNIS G. HABEOS Date of birth: December 6, 1958 Place of birth: Skurtu, Greece Nationality: Greek Marital status: Married Work Address: Department of Medicine, School of Medicine, University of Patras, 26 110 Patras, Greece Tel.: (+30) 2610 969130; E-mail: ihabeos@med.upatras.gr EDUCATION/TRAINING 1984: M.D., University of Athens Medical School, Athens, Greece 1984-1987: Military service at 401 Military Hospital of Athens, Greece 1988-1990: Internal medicine residency at ‘Laiko’ Hospital of Athens, Greece 1990-1993: Internal medicine residency at Morristown Memorial Hospital (Columbia University), NY, U.S.A. (Board certified in USA in internal medicine) 1993-1997: Endocrinology diabetes and metabolism fellowship at New York University Medical Center, NY, U.S.A. 2003: PH.D., Department of Endocrinology, School of Medicine, University of Patras, Patras, Greece Thesis Title: "Hereditary haemochromatosis and Diabetes mellitus” PROFESSIONAL POSITIONS 1997-1999: Private practice of endocrinology 1999-present: Medical staff at the University of Patras School of Medicine. My main interest has been diabetes mellitus 2004-2008: Lecturer in Internal Medicine-Metabolism, department of internal medicine, division of endocrinology, School of Medicine, University of Patras. 2008- Present: Assistant professor in Internal Medicine-Endocrinology and Metabolism

Προπτυχιακά Μαθήματα

• ΕΙΣΑΓΩΓΗ ΣΤΙΣ ΚΛΙΝΙΚΕΣ ΔΕΞΙΟΤΗΤΕΣ - ΠΡΩΤΕΣ ΒΟΗΘΕΙΕΣ (Εξάμηνο: Β)
• ΚΛΙΝΙΚΕΣ ΔΕΞΙΟΤΗΤΕΣ Ι (Εξάμηνο: Γ)
• ΚΛΙΝΙΚΕΣ ΔΕΞΙΟΤΗΤΕΣ ΙΙ (Εξάμηνο: Δ)
• ΕΝΔΟΚΡΙΝΕΙΣ ΑΔΕΝΕΣ (Εξάμηνο: Ζ)
• ΠΑΘΟΛΟΓΙΑ (ΚΑΡΔΙΟΛΟΓΙΑ/ΝΕΦΡΟΛΟΓΙΑ) (Εξάμηνο: Θ & Ι)
• ΕΝΔΟΚΡΙΝΟΛΟΓΙΑ (ΚΛΙΝΙΚΗ ΑΣΚΗΣΗ) (Εξάμηνο: ΙΑ & ΙΒ)

Επιλεγμένες Δημοσιεύσεις

1. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Chartoumpekis D, Ziros PG, Psyrogiannis A, Papavassiliou AG, Kyriazopoulou V, Sykiotis G, Habeos IG. Diabetes. 2011 Aug 18; Epub ahead of print PMID: 21852674 2: Chartoumpekis DV, Ziros PG, Sykiotis GP, Zaravinos A, Psyrogiannis AI, Kyriazopoulou VE, Spandidos DA, Habeos IG. Nrf2 activation diminishes during adipocyte differentiation of ST2 cells. Int J Mol Med. 2011 Jul 29. 3: Chartoumpekis DV, Habeos IG, Ziros PG, Psyrogiannis AI, Kyriazopoulou VE, Papavassiliou AG. Brown Adipose Tissue Responds to Cold and Adrenergic Stimulation by Induction of FGF21. Mol Med. 2011;17 (7-8):736-40. 4: Sykiotis GP, Habeos IG, Samuelson AV, Bohmann D. The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):41-8. Review. 5: Chartoumpekis D, Ziros PG, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG, Habeos IG. Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway. Biochem Biophys Res Commun. 2010 May 28;396 (2):463-6. 6: Habeos IG, Ziros PG, Chartoumpekis D, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG. Simvastatin activates Keap1/Nrf2 signaling in rat liver. J Mol Med (Berl). 2008 Nov;86 (11):1279-85 7: Habeos I, Ziros PG, Psyrogiannis A, Vagenakis AG, Papavassiliou AG. Statins and transcriptional regulation: the FXR connection. Biochem Biophys Res Commun. 2005 Aug 26;334 (2):601-5. 8: Ziros PG, Georgakopoulos T, Habeos I, Basdra EK, Papavassiliou AG. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta. J Bone Miner Res. 2004 Nov;19(11):1892-904. 9: Ziros PG, Gil AP, Georgakopoulos T, Habeos I, Kletsas D, Basdra EK, Papavassiliou AG. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem. 2002 Jun 28;277(26):23934-41 10: Hadzic E, Habeos I, Raaka BM, Samuels HH. A novel multifunctional motif in the amino-terminal A/B domain of T3Ralpha modulates DNA binding and receptor dimerization. J Biol Chem. 1998 Apr 24;273(17):10270-8.